Skip to main content

Amesite Inc.

corporate_fare Company Profile

Amesite Inc.

AMST·NASDAQ·Technology·CIK 0001807166

Amesite Inc. is a technology company that builds and commercializes AI-powered solutions for enterprises and professionals, with a particular focus on the post-acute healthcare market. In fiscal 2026, the company launched a census-based Enterprise tier featuring EMR compatibility, automated interdisciplinary team reporting, and configurable documentation. During the same fiscal year, Amesite introduced the AI-native NurseMagic™ EMR capability and secured its largest enterprise deployment to date, serving an approximately 2,700-patient census. Amesite operates through two product lines: NurseMagic™ and LynkMagic™. NurseMagic™ solutions include a B2B enterprise application and a B2C solution for individual healthcare professionals. LynkMagic™ provides enterprise AI solutions for healthcare and related organizations. The company's products support documentation, workflow, compliance, and oversight, and are designed to improve operational quality and efficiency. The B2C NurseMagic™ app connects directly with working nurses and caregivers, offering tools to reduce documentation time, simplify communication, and support daily workflow. The B2B NurseMagic™ solution serves healthcare businesses, including home health, skilled nursing, hospice, and non-clinical segments. Enterprises adopting NurseMagic™ aim to improve workflow efficiency, data security, and regulatory compliance. Amesite's offerings are engineered for fast, secure deployment and measurable value in demanding business environments.

Amesite Inc. (NASDAQ:AMST) is a publicly traded company in the Technology sector. Wiseek has independently scored 23 items for AMST at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Amesite Inc. Files S-1 for Highly Dilutive $4.47M Offering to Address Going Concern and Nasdaq Deficiency
  • Amesite Secures Trading Partner Agreement, Integrating NurseMagic™ with Leading Homecare Platform for Billions in Services
  • Amesite Reports Substantial Doubt About Going Concern and Nasdaq Listing Deficiency Amidst Q2 Financials

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
364.78K
Net Income
-3.1M
Diluted EPS
-0.63
Op. Cash Flow
-2.15M
Free Cash Flow
-2.15M
Operating Income
-3.14M
Cash & Equivalents
2.3M
Debt / Equity
0.00×
Net Margin
-8.49×
Shares Outstanding
6.55M sh
Source: 10-K · filed 2026-09-23 · accession 0001213900-26-102676
$0.5527 +8.37% today
52-week range · as of 2026-11-13 $0.46 – $2.9
Market cap
$3.34M
Volume
31.9K (0.0× avg)
3-mo avg 658K
Live data · 2026-11-22 04:06 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AMST - Filings & News (Page 2)

AMST
Apr 20, 2026, 4:00 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $1.76
Real-time Price: $0.552693 info
Change: -$1.21 (-69%) info
Market Cap: $3.34M info
AMST
Mar 26, 2026, 10:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.74
Real-time Price: $0.552693 info
Change: -$1.19 (-68%) info
Market Cap: $3.34M info
AMST
Feb 05, 2026, 6:46 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.89
Real-time Price: $0.552693 info
Change: -$1.34 (-71%) info
Market Cap: $3.34M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets